Basal Insulin Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Lantus, Levemir, Toujeo, Others); Application (Type I Diabetes, Type II Diabetes, Gestational Diabetes, Prediabetes); End User (Hospitals, Clinics, Others) and Geography

Code: RW00014037127
The Insight Partners
May-2021
Life Sciences
150 Pages

MARKET INTRODUCTION
Diabetes is a type of a metabolic disorder characterized by a high blood sugar level over a prolonged period. Symptoms often include frequent urination, increased thirst, and increased appetite.The main job of basal insulin is to keep one's blood glucose levels stable during periods of fasting, like while sleeping. During fasting, the liver continuously secretes glucose into the bloodstream. Basal insulin helps maintain these glucose levels. Without basal insulin, glucose levels would rise at an alarming rate. It ensures that one's cells are fed with a constant glucose stream to burn for energy throughout the day.

MARKET DYNAMICS
The basal insulinmarket has shown a significant evolution over the forecast period.The rise of the basal insulin market is driven by therising prevalence of diabetes, the growing geriatric population, technological advancements in insulin delivery devices, and increasing population exposure to risk factors leading to diabetes.Approximately 100 million individuals worldwide need insulin, including all individuals living with type 1 diabetes and 10-25% of individuals with type 2 diabetes. Basal insulin is the most widely used insulin in diabetic patients owing to its long-acting effect. However, although insulin has been used in the treatment of diabetes for over 90 years, globally, more than half of those who need insulin today are still unable to afford and access it, which is likely to restrict the market's growth. Conversely, product launches are boosting the market's growth. For instance, Tresiba, launched by Novo Nordisk in 2016, received encouraging feedback from the patients and is expected to show tremendous growth during the forecast period (2019-2024) due to its ultra-long-acting effect.

MARKET SCOPE
The "Basal InsulinMarket Analysis to 2027" is a specialized and in-depth study of thehealthcare industry's pharmaceuticals,focusing on the global market trend analysis. This report outlines the basal insulinmarket with detailed market segmentation bytype, application, and end-user. The basal insulinmarket isestimated to witness a high rise during the forecast period. It focuses on the vital statistics on leading players' market status in the basal insulin market and provides key opportunities and trends.

MARKET SEGMENTATION
The market is categorized based onthetype, application, and end user. Based on thetype, the market is segmented aslantus, levemir, toujeo, and others. Based on the application,the segmentationof the market is into type I diabetes, type II diabetes, gestational diabetes, and prediabetes. Basedon end user,the segmentation of the market is intohospitals,clinics,and others.

REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both quantitative and qualitative information. It offers a sketch and forecast of the basal insulinmarket based onvarious segments.The report also consists ofmarket size and forecast estimates from the year 2018 to2027with respect to five main regions, namely; North America,Asia-Pacific (APAC), Europe,Middle East, and Africa (MEA), and South & Central America (SCAM). The basal insulinmarket by each region is then sub-segmented into respective countries and segments. It comprises the analysis and forecast of 18 countriesglobally and the recent trend and opportunities prevailing in the region.

The report analyzes factors affecting the basal insulinmarket from both the demand and supply sides. Furthermore, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also consists of precise PEST analysis for all five regions, namely, North America, Asia Pacific,Europe, Middle East, and Africa, and South & Central America, after assessing political, social, economic,and technological factors affecting the basal insulinmarket in these regions.

MARKET PLAYERS
The report contains critical developments in the basal insulinmarket as inorganic and organic growth strategies. Several companies are pivoting on organic growth strategies like product launches, product approvals, and others, such aspatentsand events. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Various such activities have paved the path for elaboratingthe business and customer base of market players. The market players from the basal insulinmarket are estimated to have profitable growth opportunities in the coming years with the higher demand for basal insulinin the global market. Given below is the list of a few companies engaged in the basal insulinmarket.
The report also offers key players' profiles in the basal insulin market and their SWOT analysis and market strategies.The report also focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided,critical development in the past five years.

- Novo Nordisk
- Sanofi
- Eli Lilly and Company.
- Biocon.
- Julphar
- BoehringerIngelheim.
- Teva Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Company
- Pfizer
- GlaxoSmithKline plc.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. PUBLISHERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Basal Insulin Market - By Type
1.3.2 Basal Insulin Market - By Application
1.3.3 Basal Insulin Market - By End User
1.3.4 Basal Insulin Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. BASAL INSULIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. BASAL INSULIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BASAL INSULIN MARKET - GLOBAL MARKET ANALYSIS
6.1. BASAL INSULIN - GLOBAL MARKET OVERVIEW
6.2. BASAL INSULIN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. BASAL INSULIN MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. LANTUS
7.3.1. Overview
7.3.2. Lantus Market Forecast and Analysis
7.4. LEVEMIR
7.4.1. Overview
7.4.2. Levemir Market Forecast and Analysis
7.5. TOUJEO
7.5.1. Overview
7.5.2. Toujeo Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. BASAL INSULIN MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. TYPE I DIABETES
8.3.1. Overview
8.3.2. Type I Diabetes Market Forecast and Analysis
8.4. TYPE II DIABETES
8.4.1. Overview
8.4.2. Type II Diabetes Market Forecast and Analysis
8.5. GESTATIONAL DIABETES
8.5.1. Overview
8.5.2. Gestational Diabetes Market Forecast and Analysis
8.6. PREDIABETES
8.6.1. Overview
8.6.2. Prediabetes Market Forecast and Analysis
9. BASAL INSULIN MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis

10. BASAL INSULIN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Basal Insulin Market Overview
10.1.2 North America Basal Insulin Market Forecasts and Analysis
10.1.3 North America Basal Insulin Market Forecasts and Analysis - By Type
10.1.4 North America Basal Insulin Market Forecasts and Analysis - By Application
10.1.5 North America Basal Insulin Market Forecasts and Analysis - By End User
10.1.6 North America Basal Insulin Market Forecasts and Analysis - By Countries
10.1.6.1 United States Basal Insulin Market
10.1.6.1.1 United States Basal Insulin Market by Type
10.1.6.1.2 United States Basal Insulin Market by Application
10.1.6.1.3 United States Basal Insulin Market by End User
10.1.6.2 Canada Basal Insulin Market
10.1.6.2.1 Canada Basal Insulin Market by Type
10.1.6.2.2 Canada Basal Insulin Market by Application
10.1.6.2.3 Canada Basal Insulin Market by End User
10.1.6.3 Mexico Basal Insulin Market
10.1.6.3.1 Mexico Basal Insulin Market by Type
10.1.6.3.2 Mexico Basal Insulin Market by Application
10.1.6.3.3 Mexico Basal Insulin Market by End User
10.2. EUROPE
10.2.1 Europe Basal Insulin Market Overview
10.2.2 Europe Basal Insulin Market Forecasts and Analysis
10.2.3 Europe Basal Insulin Market Forecasts and Analysis - By Type
10.2.4 Europe Basal Insulin Market Forecasts and Analysis - By Application
10.2.5 Europe Basal Insulin Market Forecasts and Analysis - By End User
10.2.6 Europe Basal Insulin Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Basal Insulin Market
10.2.6.1.1 Germany Basal Insulin Market by Type
10.2.6.1.2 Germany Basal Insulin Market by Application
10.2.6.1.3 Germany Basal Insulin Market by End User
10.2.6.2 France Basal Insulin Market
10.2.6.2.1 France Basal Insulin Market by Type
10.2.6.2.2 France Basal Insulin Market by Application
10.2.6.2.3 France Basal Insulin Market by End User
10.2.6.3 Italy Basal Insulin Market
10.2.6.3.1 Italy Basal Insulin Market by Type
10.2.6.3.2 Italy Basal Insulin Market by Application
10.2.6.3.3 Italy Basal Insulin Market by End User
10.2.6.4 Spain Basal Insulin Market
10.2.6.4.1 Spain Basal Insulin Market by Type
10.2.6.4.2 Spain Basal Insulin Market by Application
10.2.6.4.3 Spain Basal Insulin Market by End User
10.2.6.5 United Kingdom Basal Insulin Market
10.2.6.5.1 United Kingdom Basal Insulin Market by Type
10.2.6.5.2 United Kingdom Basal Insulin Market by Application
10.2.6.5.3 United Kingdom Basal Insulin Market by End User
10.2.6.6 Rest of Europe Basal Insulin Market
10.2.6.6.1 Rest of Europe Basal Insulin Market by Type
10.2.6.6.2 Rest of Europe Basal Insulin Market by Application
10.2.6.6.3 Rest of Europe Basal Insulin Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Basal Insulin Market Overview
10.3.2 Asia-Pacific Basal Insulin Market Forecasts and Analysis
10.3.3 Asia-Pacific Basal Insulin Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Basal Insulin Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Basal Insulin Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Basal Insulin Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Basal Insulin Market
10.3.6.1.1 Australia Basal Insulin Market by Type
10.3.6.1.2 Australia Basal Insulin Market by Application
10.3.6.1.3 Australia Basal Insulin Market by End User
10.3.6.2 China Basal Insulin Market
10.3.6.2.1 China Basal Insulin Market by Type
10.3.6.2.2 China Basal Insulin Market by Application
10.3.6.2.3 China Basal Insulin Market by End User
10.3.6.3 India Basal Insulin Market
10.3.6.3.1 India Basal Insulin Market by Type
10.3.6.3.2 India Basal Insulin Market by Application
10.3.6.3.3 India Basal Insulin Market by End User
10.3.6.4 Japan Basal Insulin Market
10.3.6.4.1 Japan Basal Insulin Market by Type
10.3.6.4.2 Japan Basal Insulin Market by Application
10.3.6.4.3 Japan Basal Insulin Market by End User
10.3.6.5 South Korea Basal Insulin Market
10.3.6.5.1 South Korea Basal Insulin Market by Type
10.3.6.5.2 South Korea Basal Insulin Market by Application
10.3.6.5.3 South Korea Basal Insulin Market by End User
10.3.6.6 Rest of Asia-Pacific Basal Insulin Market
10.3.6.6.1 Rest of Asia-Pacific Basal Insulin Market by Type
10.3.6.6.2 Rest of Asia-Pacific Basal Insulin Market by Application
10.3.6.6.3 Rest of Asia-Pacific Basal Insulin Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Basal Insulin Market Overview
10.4.2 Middle East and Africa Basal Insulin Market Forecasts and Analysis
10.4.3 Middle East and Africa Basal Insulin Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Basal Insulin Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Basal Insulin Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Basal Insulin Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Basal Insulin Market
10.4.6.1.1 South Africa Basal Insulin Market by Type
10.4.6.1.2 South Africa Basal Insulin Market by Application
10.4.6.1.3 South Africa Basal Insulin Market by End User
10.4.6.2 Saudi Arabia Basal Insulin Market
10.4.6.2.1 Saudi Arabia Basal Insulin Market by Type
10.4.6.2.2 Saudi Arabia Basal Insulin Market by Application
10.4.6.2.3 Saudi Arabia Basal Insulin Market by End User
10.4.6.3 U.A.E Basal Insulin Market
10.4.6.3.1 U.A.E Basal Insulin Market by Type
10.4.6.3.2 U.A.E Basal Insulin Market by Application
10.4.6.3.3 U.A.E Basal Insulin Market by End User
10.4.6.4 Rest of Middle East and Africa Basal Insulin Market
10.4.6.4.1 Rest of Middle East and Africa Basal Insulin Market by Type
10.4.6.4.2 Rest of Middle East and Africa Basal Insulin Market by Application
10.4.6.4.3 Rest of Middle East and Africa Basal Insulin Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Basal Insulin Market Overview
10.5.2 South and Central America Basal Insulin Market Forecasts and Analysis
10.5.3 South and Central America Basal Insulin Market Forecasts and Analysis - By Type
10.5.4 South and Central America Basal Insulin Market Forecasts and Analysis - By Application
10.5.5 South and Central America Basal Insulin Market Forecasts and Analysis - By End User
10.5.6 South and Central America Basal Insulin Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Basal Insulin Market
10.5.6.1.1 Brazil Basal Insulin Market by Type
10.5.6.1.2 Brazil Basal Insulin Market by Application
10.5.6.1.3 Brazil Basal Insulin Market by End User
10.5.6.2 Argentina Basal Insulin Market
10.5.6.2.1 Argentina Basal Insulin Market by Type
10.5.6.2.2 Argentina Basal Insulin Market by Application
10.5.6.2.3 Argentina Basal Insulin Market by End User
10.5.6.3 Rest of South and Central America Basal Insulin Market
10.5.6.3.1 Rest of South and Central America Basal Insulin Market by Type
10.5.6.3.2 Rest of South and Central America Basal Insulin Market by Application
10.5.6.3.3 Rest of South and Central America Basal Insulin Market by End User

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. BASAL INSULIN MARKET, KEY COMPANY PROFILES
12.1. NOVO NORDISK
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SANOFI
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ELI LILLY AND COMPANY.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIOCON.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JULPHAR
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BOEHRINGER INGELHEIM.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BRISTOL-MYERS SQUIBB COMPANY
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. GLAXOSMITHKLINE PLC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT PUBLISHERS
13.2. GLOSSARY OF TERMS

The List of Companies

1. Novo Nordisk
2. Sanofi
3. Eli Lilly and Company.
4. Biocon.
5. Julphar
6. Boehringer Ingelheim.
7. Teva Pharmaceutical Industries Ltd.
8. Bristol-Myers Squibb Company
9. Pfizer
10. GlaxoSmithKline plc.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Prescription Dermatology Therapeu.. Dermatological therapeutics are pharmaceuticals that specifi..

Global Avanafil Market Report - Producti.. This report elaborates the market size, market characteris..

Global Treatment for Gastroparesis Marke.. This report elaborates the market size, market characteris..

Global Patient Engagement Solutions Mark.. Patient engagement refers to the process of enabling the act..

Global Vinorelbine Market Report - Produ.. Vinorelbine is an anti-mitotic chemotherapy drug that is use..

Global Color Blind Test Market Report - .. This report elaborates the market size, market characteris..

Global Breast Cancer Screening Tests Mar.. This report elaborates the market size, market characteris..

Global Seasonal Influenza Treatment Mark.. Seasonal influenza is an acute respiratory infection caused ..

Global Veterinary Point-of-Care Diagnost.. This report elaborates the market size, market characteris..

Global Sonic Facial Cleansing Brush Mark.. This report elaborates the market size, market characteris..

Global Cell Therapy Market Report - Prod.. Cell therapy is therapy in which cellular material is inject..

Global Film Dressings Market Report - Pr.. This report elaborates the market size, market characteris..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE